Healthcare provider profile · identity verified

Henry A. Braa, MD

Internal Medicine · REDWOOD CITY, CA · NPI 1750469300

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	398	149
Lisinopril	Lisinopril	358	131
Losartan Potassium	Losartan Potassium	225	84
Amlodipine Besylate	Amlodipine Besylate	220	82
Atenolol	Atenolol	206	75
Levothyroxine Sodium	Levothyroxine Sodium	179	63
Simvastatin	Simvastatin	139	53
Hydrochlorothiazide	Hydrochlorothiazide	135	49
Metformin Hcl	Metformin Hcl	130	50
Metoprolol Succinate	Metoprolol Succinate	111	41
Famotidine	Famotidine	106	55
Terazosin Hcl	Terazosin Hcl	105	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	98	17
Metformin Hcl Er	Metformin Hcl	89	36
Glipizide	Glipizide	82	28
Ibuprofen	Ibuprofen	79	40
Albuterol Sulfate Hfa	Albuterol Sulfate	75	42
Tamsulosin Hcl	Tamsulosin Hcl	75	29
Gabapentin	Gabapentin	74	33
Lovastatin	Lovastatin	72	27
Pantoprazole Sodium	Pantoprazole Sodium	72	32
Omeprazole	Omeprazole	68	28
Furosemide	Furosemide	64	27
Metoprolol Tartrate	Metoprolol Tartrate	63	25
Fluticasone Propionate	Fluticasone Propionate	60	38
Allopurinol	Allopurinol	50	16
Montelukast Sodium	Montelukast Sodium	50	16
Trazodone Hcl	Trazodone Hcl	48	21
Finasteride	Finasteride	46	16
Fluoxetine Hcl	Fluoxetine Hcl	43	20
Rosuvastatin Calcium	Rosuvastatin Calcium	43	18
Alvesco	Ciclesonide	42	22
Wixela Inhub	Fluticasone Propion/Salmeterol	41	11
Alendronate Sodium	Alendronate Sodium	39	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	13
Mirtazapine	Mirtazapine	34	suppressed
Hydrocortisone	Hydrocortisone	33	26
Duloxetine Hcl	Duloxetine Hcl	32	13
Meloxicam	Meloxicam	32	17
Ozempic	Semaglutide	32	suppressed
Jardiance	Empagliflozin	28	13
Potassium Chloride	Potassium Chloride	28	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	27	11
Prednisone	Prednisone	26	22
Triamcinolone Acetonide	Triamcinolone Acetonide	26	18
Lorazepam	Lorazepam	25	16
Clobetasol Propionate	Clobetasol Propionate	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Azithromycin	Azithromycin	23	21
Pregabalin	Pregabalin	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Sertraline Hcl	Sertraline Hcl	21	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	20	20
Diazepam	Diazepam	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Digoxin	Digoxin	19	suppressed
Fluconazole	Fluconazole	18	suppressed
Lactulose	Lactulose	17	13
Propranolol Hcl	Propranolol Hcl	17	suppressed
Cephalexin	Cephalexin	16	14
Fluocinonide	Fluocinonide	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Humulin N	Insulin Nph Human Isophane	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Naproxen	Naproxen	14	suppressed
Nystatin	Nystatin	14	13
Ondansetron Odt	Ondansetron	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Savella	Milnacipran Hcl	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Metronidazole	Metronidazole	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Temazepam	Temazepam	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error